Search
forResearch 10 of 1000+
- Permanent chemotherapy-induced nonscarring alopecia and premature ovarian failure
- Menopause in Women, Andropause in Men: Myth, Reality, and Management
- Biological effects of human placental extracts - variations in manufacturing methods and compositions
- Practical Geriatrics: Maintaining Sexual Health After Menopause
- Female pattern hair loss, biological ageing and the Leiden Longevity study
- Androgen treatment in women
- Steroid Hormones of Reproduction and Sexual Development
- Le vieillissement de la peau et du follicule pileux : de la caractérisation clinique à l'étude fonctionnelle
- Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria
- Managing Menopausal Skin: A Clinician’s Review
Community 3 of 11
- Why hasn’t anyone made a "DHT sponge" biologic yet???
- HMI-115 update: Chime Biologics and Hope Medicine Enter Manufacturing Agreement to Speed up the Launch of First-in-class Antibody Drug HMI-115 Targeting Endometriosis and Androgenic Alopecia
- 42 male - 8 months (Is this the biological limit?)
Learn
— no results
Try a deeper search in learn →